(1)
Pamukcuoglu, M.; Baysal, N. A.; Pepeler, M. S. The Infection Rate in New Diagnosis and Relapsed Refractory Multiple Myeloma Patients Who Had Bortezomib-Based Chemotherapy and Relationship Between Development of Infection and Lymphocyte Monocyte Ratio. Eur Res J 2021, 7 (6), 541-549. https://doi.org/10.18621/eurj.855510.